TrialInternational journal of clinical oncology2019

A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).

Hiroyuki Fujiwara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.